Scholarlink

<p>Exome sequencing (ES) is emerging as a cost-effective and useful diagnostic tool for identifying pediatric neurological disorders with diverse clinical presentations. This retrospective study reviewed ES data from January 2021 to November 2023 for children with neurological symptoms that met the inclusion criteria at the genetic laboratory, Lok Nayak Hospital, New Delhi. Eighty-three children with the mentioned neurological features underwent proband-only ES. Of these, 43/83 (51.80%) were diagnosed with pathogenic (P) or likely pathogenic (LP) variants, 36/83 (43.37%) had variants of unknown significance (VUS), and 10/83 (12.04%) showed no variant. A definitive diagnosis could be established in 46.98% (39/83) of the patients. The results demonstrate the high diagnostic yield of ES for children with diverse neurological phenotypes, making it a useful tool for diagnosing pediatric neurological disorders. Achieving specific genetic diagnosis would not only be useful in planning further management and prognostication, but would also aid in offering genetic counselling and prenatal diagnosis to the parents of the affected proband, if they are planning any future pregnancies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genetic insights: proband- only exome sequencing in pediatric neurological disorders

  • 期刊论文

  • 发表日期：

    2026年3月21日

查看全文
  • Komal Uppal,
  • Himani Kaushik,
  • Meenakshi Bothra Gupta,
  • Sunil Kumar Polipalli,
  • Somesh Kumar,
  • Seema Kapoor

摘要

Exome sequencing (ES) is emerging as a cost-effective and useful diagnostic tool for identifying pediatric neurological disorders with diverse clinical presentations. This retrospective study reviewed ES data from January 2021 to November 2023 for children with neurological symptoms that met the inclusion criteria at the genetic laboratory, Lok Nayak Hospital, New Delhi. Eighty-three children with the mentioned neurological features underwent proband-only ES. Of these, 43/83 (51.80%) were diagnosed with pathogenic (P) or likely pathogenic (LP) variants, 36/83 (43.37%) had variants of unknown significance (VUS), and 10/83 (12.04%) showed no variant. A definitive diagnosis could be established in 46.98% (39/83) of the patients. The results demonstrate the high diagnostic yield of ES for children with diverse neurological phenotypes, making it a useful tool for diagnosing pediatric neurological disorders. Achieving specific genetic diagnosis would not only be useful in planning further management and prognostication, but would also aid in offering genetic counselling and prenatal diagnosis to the parents of the affected proband, if they are planning any future pregnancies.